SCHEMBL4964968

SCHEMBL4964968

C[Si](C)(C)COc1ccc(C=C(C(N)=O)C(N)=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.42
NR1H4 Q96RI1 1/20 0.41
MAPT P10636 4/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
GAA P10253 2/20 0.40
ALDH1A1 P00352 5/20 0.40
HPGD P15428 1/20 0.37
PARP10 Q53GL7 1/20 0.37
LMNA P02545 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
MAPK1 P28482 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
S1PR4 O95977 1/20 0.36
S1PR1 P21453 1/20 0.36
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4966299 0.88 NR1H4 (0.55) KDM4ENR1H4MAPTNPC1RAB9A
SCHEMBL4966295 0.88 NR1H4 (0.55) KDM4ENR1H4MAPTNPC1RAB9A
SCHEMBL14202743 0.88 ALDH1A1 (0.38) KDM4ENR1H4MAPTNPC1RAB9A
SCHEMBL4964476 0.86 TP53 (0.46) KDM4ENR1H4MAPTRAB9AALDH1A1
SCHEMBL4964229 0.83 NR1H4 (0.46) NR1H4MAPTHPGDLMNAMEN1
SCHEMBL4968587 0.81 NR1H4 (0.64) KDM4ENR1H4MAPTNPC1RAB9A
SCHEMBL14273808 0.78 NR1H4 (0.41) KDM4ENR1H4MAPTNPC1RAB9A
SCHEMBL4966708 0.77 NR1H4 (0.47) KDM4ENR1H4MAPTALDH1A1HPGD
SCHEMBL4963610 0.77 NR1H4 (0.47) KDM4ENR1H4MAPTALDH1A1HPGD
SCHEMBL4964458 0.74 ALDH1A1 (0.52) KDM4EMAPTRAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080171802-A1 Methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function and photostabilizing methods L'OREAL (FR) 2008-07-17 US disclosed
US-20080171802-A1 Methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function and photostabilizing methods L'OREAL (FR) 2008-07-17 US disclosed
US-7354571-B2 Photoprotective compositions comprising methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function L'OREAL (FR) 2008-04-08 US disclosed
US-7354571-B2 Photoprotective compositions comprising methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function L'OREAL (FR) 2008-04-08 US disclosed
EP-1594880-B1 PHOTOPROTECTIVE COMPOSITIONS BASED ON METHYLTRIALKYLSILANES CONTAINING A CINNAMATE, CINNAMAMIDE, BENZALMALONAMIDE OR BENZALMALONATE FUNCTION OREAL (FR) 2008-03-19 EP disclosed
EP-1594880-B1 PHOTOPROTECTIVE COMPOSITIONS BASED ON METHYLTRIALKYLSILANES CONTAINING A CINNAMATE, CINNAMAMIDE, BENZALMALONAMIDE OR BENZALMALONATE FUNCTION OREAL (FR) 2008-03-19 EP disclosed
US-20060018848-A1 Photoprotective compositions comprising methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function L'OREAL (FR) 2006-01-26 US disclosed
EP-1594880-A1 PHOTOPROTECTIVE COMPOSITIONS BASED ON METHYLTRIALKYLSILANES CONTAINING A CINNAMATE, CINNAMAMIDE, BENZALMALONAMIDE OR BENZALMALONATE FUNCTION L'OREAL (FR) 2005-11-16 EP disclosed
WO-2004067539-A1 PHOTOPROTECTIVE COMPOSITIONS BASED ON METHYLTRIALKYLSILANES CONTAINING A CINNAMATE, CINNAMAMIDE, BENZALMALONAMIDE OR BENZALMALONATE FUNCTION L'OREAL (FR) 2004-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171802-A1 Methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function and photostabilizing methods KCNN1, KCNN2, CMBL KDM4E 220/4885NR1H4 4870/4885MAPT 3422/4885
US-20060018848-A1 Photoprotective compositions comprising methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function TRPM7, TRPM6, KCNN1 KDM4E 310/4885NR1H4 4861/4885MAPT 3803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.